Autoimmune haemolytic anaemia: a review and report of four cases

Orvosi hetilap
Renáta NyilasLajos Gergely

Abstract

Treatment of autoimmune haemolytic anaemia is still a challenge to clinicians. Even today it may be lethal. Half of the cases are secondary due to an underlying disease, and the others are primary or idiopathic cases. According to the specificity and type of autoantibodies there are warm and cold type forms of autoimmune haemolytic anaemia. The hallmark of the diagnosis is to detect the presence of haemolysis by clinical and laboratory signs and detect the underlying autoantibodies. Treatment of autoimmune haemolytic anaemia is still a challenge to clinicians. We still loose patients due to excessive haemolysis or severe infections caused by immunosuppression. First line treatment is corticosteroids. Other immunosuppressive agents like: cyclophosphamide, azathioprine, cyclosporine or the off label rituximab can be used in case of corticosteroid refractoriness. Splenectomy is a considerable option in selective cases. The authors discuss treatment options and highlight difficulties by presenting 4 cases.

References

May 1, 1985·Archives of Surgery·W W Coon
Dec 15, 1993·Annals of Internal Medicine·D T BoumpasJ E Balow
Apr 1, 1993·The Journal of Clinical Investigation·J P LeddyS I Rosenfeld
Jul 1, 1996·Annals of Surgery·J L FlowersA L Imbembo
May 20, 1998·Dermatologic Clinics·R S LesterN H Shear
Mar 29, 2002·American Journal of Hematology·Bradley C Gehrs, Richard C Friedberg
Mar 22, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BoyeA Engert
Oct 26, 2005·Journal of Autoimmunity·D Stahl, W Sibrowski
Oct 2, 2007·Blood Reviews·Charles H Packman
Nov 26, 2009·Autoimmunity Reviews·Jean-Francois Lambert, Urs E Nydegger
Dec 17, 2009·Hematology·Philip C Hoffman
May 5, 2011·Nature Medicine·Margarita Dominguez-VillarDavid A Hafler
Jan 26, 2012·International Journal of Laboratory Hematology·M H FayekG Kamal
Nov 3, 2012·American Journal of Surgery·Nirav Y PatelWayne A Bottner
Sep 17, 2013·European Journal of Haematology·Wilma BarcelliniAlberto Zanella
Oct 10, 2013·Clinical & Developmental Immunology·Bainan Liu, Wangang Gu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

© 2022 Meta ULC. All rights reserved